(19)
(11) EP 1 155 021 A1

(12)

(43) Date of publication:
21.11.2001 Bulletin 2001/47

(21) Application number: 00904573.3

(22) Date of filing: 26.01.2000
(51) International Patent Classification (IPC)7C07F 9/06, C07D 311/04, A61K 9/00, A61K 31/66, A61K 31/35
(86) International application number:
PCT/US0001/923
(87) International publication number:
WO 0044/757 (03.08.2000 Gazette 2000/31)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 27.01.1999 US 117567 P
01.02.1999 US 118198 P

(71) Applicant: Zielinski Laboratory
San Diego, CA 92121 (US)

(72) Inventor:
  • ZIELINSKI, Jan, E.
    Vista, CA 92083 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) HESPERITIN PRO-FORMS WITH ENHANCED BIOAVAILABILITY